Advertisement

Topics

Arbor Pharmaceuticals' Early Puberty Treatment Gains FDA Approval

10:45 EDT 3 Jul 2017 | Drug Discovery Development

Triptodur (triptorelin), for extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty with once every six-month intramuscular injection dosing for children with central precocious puberty.
Contributed Author: 
Arbor Pharmaceuticals
Topics: 

Original Article: Arbor Pharmaceuticals' Early Puberty Treatment Gains FDA Approval

NEXT ARTICLE

More From BioPortfolio on "Arbor Pharmaceuticals' Early Puberty Treatment Gains FDA Approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...